NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Reza Shojaei: On The 2nd Day of IPAW 2025, Let’s Focus on Patients, The Real Reason Plasma Matters!
Reza Shojaei/LinkedIn
Oct 8, 2025, 04:45

Reza Shojaei: On The 2nd Day of IPAW 2025, Let’s Focus on Patients, The Real Reason Plasma Matters!

Reza Shojaei, Chief Operating Officer at Canadian Plasma Resources, shared on LinkedIn:

”On the second day of IPAW 2025, let’s focus on patients, the real reason plasma matters.

Plasma-derived medicines treat life-threatening conditions such as primary immune deficiencies, hemophilia, and hereditary angioedema.

For many, these therapies are not optional; they are the only available treatment, turning what used to be fatal diseases into manageable conditions.

Every donation ensures someone, somewhere, gets another chance at health, at family life, at simply living fully.

Behind each unit of plasma is a powerful chain: a donor’s generosity, a patient’s survival, and then a family’s hope.

Let’s use this week to amplify the voices of patients and remind the world that plasma saves lives every single day.

If you know someone whose life has been touched by plasma therapies, share their story on social media, because awareness grows stronger when it’s personal.”

Reza Shojaei: On The 2nd Day of IPAW 2025, Let's Focus on Patients, The Real Reason Plasma Matters!

Stay updated on emerging topics in transfusion medicine with Hemostasis Today.

Health Hematology Hemostasis Hemostasis Today IPAW2025 Medicine Plasma Donation Reza Shojaei thrombosis Transfusion Medicine
NewsFeed